[1] L. Dwyer, D. Dowding, R. Kearney, What is known from the existing literature about self-management of pessaries for pelvic organ prolapse? A scoping review protocol, BMJ Open. 12 (2022) e055587.
[2] B.B. Zeiger, S. da Silva Carramão, C.A. del Roy, T.T. da Silva, S.M. Hwang, A.P.F. Auge, Vaginal pessary in advanced pelvic organ prolapse: impact on quality of life, Int Urogynecol J. 33 (2022) 2013–2020.
[3] D. Vardon, M. Martin-Lasnel, A. Agostini, R. Fauvet, A.-C. Pizzoferrato, Vaginal pessary for pelvic organ prolapse: A survey among french gynecological surgeons, J Gynecol Obstet Hum Reprod. 50 (2021) 101833.
[4] B.B. Zeiger, S. da Silva Carramão, C.A. del Roy, T.T. da Silva, S.M. Hwang, A.P.F. Auge, Vaginal pessary in advanced pelvic organ prolapse: impact on quality of life, Int Urogynecol J. 33 (2022) 2013–2020.
[5] F. Ai, Y. Wang, J. Wang, L. Zhou, S. Wang, Effect of estrogen on vaginal complications of pessary use: a systematic review and meta-analysis, Climacteric. (2022) 1–10.
[6] T. Tam, M.F. Davies, Vaginal pessaries, CRC Press, 2019.
[7] P.L. Yeo, C.L. Lim, S.M. Chye, A.P.K. Ling, R.Y. Koh, Niosomes: a review of their structure, properties, methods of preparation, and medical applications, Asian Biomedicine. 11 (2017) 301–314.
[8] S. Palacios, F. Losa, D. Dexeus, J. Cortés, Beneficial effects of a coriolus versicolor, (n.d.).
[9] S. Palacios, F. Losa, D. Dexeus, J. Cortés, Beneficial effects of a Coriolus versicolor-based vaginal gel on cervical epithelization, vaginal microbiota and vaginal health: a pilot study in asymptomatic women, BMC Womens Health. 17 (2017) 1–6.
[10] P. Aragón, F. Losa, M.C. Abad, I. Vallbuena, D. Khorsandi, Efectividad del masaje perineal con un gel vulvar a base de
fitosomas de Centella asiática, durante la gestación y el trabajo del parto, Tokoginecol Pract. (2019) 256–261.
[11] S. Palacios, F. Losa, J. Combalia, C. Emsellem, Y. Gaslain, Evaluation of the Level of Satisfaction of Patients with the Use of a Newly Marketed Vaginal Gel (Satisvag Survey), Gynecol Obstet. 8 (2018) 2161–2932.
[12] F. Losa, S. Palacios, S.P.G. Rodríguez, L. Baquedano, D. Khorsandi, Vaginal Dysbiosis Management and the Efficacy of a Non-Hormonal Hyaluronic Acid-Based Vaginal Gel (Palomacare®) as an Adjuvant Treatment: The Palomascopia Survey,
Obstet Gynecol Cases Rev. 9 (2022) 222.
[13] D. Khorsandi, Evaluation of the Benefits of a Newly Marketed Vaginal Gel (Palomacare®) on Vaginal Health of Peri and Postmenopausal Women (Atrovag Survey), EC Gynaecol. 7 (2018) 104–106.
)
)